Arcadia Biosciences (17D) Q4 2025 Earnings Report
DE:17D Q4 2025 EPS Results
- Actual EPS
- -EUR 0.87
- Consensus EPS
- -EUR 0.59
- Beat/Miss
- Missed by -EUR 0.28
- One Year Ago EPS
- -EUR 2.66
DE:17D Q4 2025 Revenue Results
- Actual Revenue
- EUR 805.59K
- Expected Revenue
- EUR 1.25M
- Beat/Miss
- Missed by -EUR 446.16K
- YoY Revenue Growth
- -25.90%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 03/26/2026
- Time
- After Close
- Conference Call
- Thursday, March 26, 2026
DE:17D Upcoming Earnings
Arcadia Biosciences's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:17D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | ―- | -0.76 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | ―-1.87 | -2.91 | 35.89% (+1.05) | |
| May 14, 2026 | 2026 (Q1) | ―-1.89 | 1.7 | -211.05% (-3.59) | |
| Mar 26, 2026 | 2025 (Q4) | -0.59-0.87 | -2.66 | 67.45% (+1.80) | |
| Nov 07, 2025 | 2025 (Q3) | -0.48-0.76 | -1.06 | 28.14% (+0.30) | |
| Aug 14, 2025 | 2025 (Q2) | -0.71-2.91 | 0.7 | -517.95% (-3.61) | |
| May 08, 2025 | 2025 (Q1) | -0.881.70 | -1.59 | 206.74% (+3.29) | |
| Mar 20, 2025 | 2024 (Q4) | -0.80-2.66 | -1.88 | -41.90% (-0.79) | |
| Nov 12, 2024 | 2024 (Q3) | -0.72-1.06 | -1.69 | 37.57% (+0.63) | |
| Aug 13, 2024 | 2024 (Q2) | 1.390.70 | 0.55 | 27.87% (+0.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
